Israel Englander Pyxis Oncology, Inc. Transaction History
Millennium Management LLC
- $192 Billion
- Q2 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 3,539,860 shares of PYXS stock, worth $3.68 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,539,860
Previous 2,485,276
42.43%
Holding current value
$3.68 Million
Previous $2.44 Million
59.88%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding PYXS
# of Institutions
74Shares Held
22.9MCall Options Held
0Put Options Held
0-
Laurion Capital Management LP New York, NY3.63MShares$3.77 Million0.07% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$2.9 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.5MShares$2.6 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$2.24 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.04MShares$1.08 Million0.26% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $36.5M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...